The FDA authorized the emergency use of the anti-viral after studies showed it shortened the recovery time for people hospitalized with COVID-19.
University Communications
The FDA authorized the emergency use of the anti-viral after studies showed it shortened the recovery time for people hospitalized with COVID-19.